Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Pipeline
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. For more information about the Company and updates, please visit www.palvellatx.com or follow us on LinkedIn.

Continue

Pieris Pharmaceuticals, Inc. Sitemap

  • Home
  • About
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • Media
      • IR Calendar
      • Email Alerts
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Form 8937
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Corporate Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact
  • Imprint
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Contact Us
© 2025 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences